Novo Nordisk and Gates Foundations

March 25, 2022 by

The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have launched the Pandemic Antiviral Discovery (PAD) initiative to catalyze discovery and early development of antiviral medicines for future pandemics. This initiative’s first request for proposals (RFP) will focus on henipavirus, a subfamily of paramyxovirus that includes Nipah virus – a pathogen with an estimated fatality rate of 40% to 75%. Researchers from around the world are encouraged to submit proposals; the application deadline is May 5, 2022. Future RFPs will be announced on the initiative’s website.

Perspective on COVID-19

The Bill & Melinda Gates Foundation continues to work with the public and private sectors in the global response to COVID-19. To learn more about the foundation’s broader work and how COVID-19 is being addressed across the foundation, please visit the foundation’s website and media center, sign-up for The Optimist newsletter, and browse videos from the 2021 Grand Challenges Annual Meeting.

Grand Challenges Partnership Network

We invite you to read summaries of the grants awarded to date through Grand Challenges initiatives with the Gates Foundation as funder or co-funder and to explore an interactive world map of projects across the broader Grand Challenges funding partner network. This map isfilling in over time, increasingly with locally led programs in the countries most affected by global health inequities.


Filed Under: Funding Opportunities